How should acute ingestion of Bispyribac‑sodium 10% suspension concentrate be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Bispyribac-Sodium 10% SC Poisoning

Immediate Stabilization and Supportive Care

The primary management of bispyribac-sodium poisoning is aggressive supportive care with focus on airway protection, hemodynamic monitoring, and seizure management, as no specific antidote exists. 1

Critical First Steps

  • Secure the airway immediately and provide respiratory support, particularly in patients with reduced Glasgow Coma Score (GCS), as this is the foundational step in poisoning management 1
  • Contact your regional Poison Control Center immediately (1-800-222-1222 in the US) while initiating treatment for case-specific guidance from medical toxicologists 1
  • Establish intravenous access for fluid resuscitation and medication administration 1
  • Monitor vital signs continuously including blood pressure, heart rate, oxygen saturation, and cardiac rhythm 1

Gastrointestinal Decontamination Considerations

  • Activated charcoal may be considered only if the patient presents within 1-2 hours of ingestion AND has a protected airway; the standard dose is 1-2 g/kg body weight 1
  • Do NOT perform gastric lavage due to lack of proven benefit and significant risks including aspiration pneumonia, dysrhythmias, and esophageal perforation 1
  • Do NOT induce emesis with ipecac as it is no longer recommended and increases aspiration risk 1
  • Do NOT administer anything by mouth including water or milk unless specifically directed by poison control, as this may cause emesis and aspiration without proven clinical benefit 2

High-Risk Clinical Features Requiring Intensive Monitoring

Neurological Complications

  • Monitor closely for altered mental status and seizures, which are the most concerning early complications 1, 3
  • Patients with reduced GCS on presentation require immediate intensive care, as all three deaths in the largest case series occurred in patients with reduced GCS (3,12, and 13) within 6 hours of ingestion 3
  • Prepare for seizure management with benzodiazepines readily available, as tonic-clonic seizures occurred in fatal cases 3

Cardiovascular Complications

  • Asystolic cardiac arrest is the primary cause of death, occurring at 5-15 hours post-ingestion in fatal cases 3
  • Implement immediate life-support measures including CPR according to American Heart Association protocols if cardiorespiratory arrest occurs 2
  • Correct critical metabolic derangements (hypotension, dysrhythmias, hypoxia) using standard resuscitation protocols 1

Clinical Course and Prognosis

  • The majority of patients develop self-limiting upper gastrointestinal symptoms with a median hospital stay of 3 days 3
  • The case fatality ratio is approximately 1.81% (95% CI 0.32-5.8%), which is relatively favorable compared to other commonly used herbicides 3
  • Significant poisoning manifests within 6 hours of ingestion; patients who remain stable beyond this timeframe typically have good outcomes 3
  • Plasma bispyribac concentrations do NOT predict severity or mortality, likely due to toxicity from non-bispyribac components (solvent or surfactant polyethylene glycol) in the formulation 3

Critical Pitfalls to Avoid

  • Do NOT delay airway management while attempting decontamination procedures 1
  • Do NOT delay EMS activation to attempt home interventions 2
  • Do NOT assume single-agent ingestion—mixed ingestions (particularly with ethanol, which occurred in fatal cases) are common and require broader toxicological assessment 1, 3
  • Do NOT rely on plasma bispyribac levels to guide clinical decision-making, as they do not correlate with outcomes 3

Specific Monitoring Parameters

  • Assess hepatic function as aromatic hydrocarbons in the formulation may cause liver injury 1
  • Monitor renal function since kidney injury may occur with significant exposure 1
  • Provide symptomatic treatment for nausea, vomiting, or abdominal pain as needed 1

References

Guideline

Management of Paradichlorobenzene Ingestion – Evidence‑Based Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Emergency Management of Rodenticide Poisoning

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.